ADPT Stock Analysis: Buy, Sell, or Hold?
ADPT - Adaptive Biotechnologies Corporation Common Stock
$14.81
0.38 (2.63%)
▲
5d:
+6.09%
30d:
-9.91%
90d:
-8.81%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 07, 2026
Get Alerted When ADPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ADPT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: ADPT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: ADPT is currently trading at $14.81, which is considered fair relative to its 30-day fair value range of $13.24 to $15.72.
Technical Outlook: Technically, ADPT is in a strong uptrend. The price is approaching resistance at $14.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ADPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.86 (+40.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ADPT is in a strong uptrend. The price is approaching resistance at $14.86. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ADPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.86 (+40.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$13.24 -
$15.72
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.8% below Wall St target ($20.86)
Fair Price Analysis
30-Day Fair Range
$13.24 -
$15.72
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$12.02
Resistance Level
$14.86
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-54.85
Wall Street Target
$20.86
(+40.8%)
Revenue Growth (YoY)
51.0%
Profit Margin
-21.5%
Share & Embed Analysis
Last updated: April 02, 2026 5:31 PM ET
Data refreshes hourly during market hours. Next update: 6:31 PM
Data refreshes hourly during market hours. Next update: 6:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Rubinstein
SELL
19060 shares
2026-03-18
Julie Rubinstein
SELL
19060 shares
2026-03-16
Julie Rubinstein
SELL
19060 shares
2026-03-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 67 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
12 analysts |
$138 | 61 BUY |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 58 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 50 HOLD |
